Cardiff Lexington Finalizes Terms for Highly Dilutive $75M Equity Purchase Facility
Summary
Cardiff Lexington has finalized the terms for an equity purchase facility with Leonite Fund I, LP, allowing the company to sell up to $75 million in common stock at a discount to market prices, potentially leading to substantial dilution for existing shareholders.
Key Events
-
Equity Purchase Facility Finalized
The company finalized an agreement to sell up to $75 million of common stock to Leonite Fund I, LP over a 36-month period, following the S-1 registration filed on June 11, 2026.
-
Significant Potential Dilution
The facility could result in the issuance of up to 50,000,000 shares, representing over 300% of current outstanding shares, with potential dilution of up to 96% of shares outstanding after issuance if the full $75 million is raised at lower prices.
-
Discounted Share Sales
Shares will be sold to Leonite at a discount of 3% below the lowest daily volume-weighted average price or lowest trading price, with a 10% discount if the price falls below $0.20.
-
Capital for Operations
Proceeds from sales to Leonite will be used for working capital and general corporate purposes, providing crucial funding for the financially distressed company, which recently reported widened net losses and a 'going concern' warning.
Analysis
This filing finalizes the terms of a previously announced equity purchase facility, providing Cardiff Lexington with access to up to $75 million in capital. While this funding is critical for the company, which recently reported widened losses and a "going concern" warning, the terms are highly dilutive. The potential issuance of up to 50 million new shares, compared to 15.28 million currently outstanding, means existing shareholders face substantial dilution. The discounted pricing further exacerbates the negative impact, and the registration of these shares for resale by the investor creates a significant overhang on the stock price. This is a necessary but costly measure for the company's survival.
At the time of this filing, CDIX was trading at $1.80 on OTC in the Industrial Applications And Services sector, with a market capitalization of approximately $27.5M. The 52-week trading range was $0.93 to $315.00. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.